Biotech · Private company
Guangzhou Henovcom Bioscience Co. Ltd.
Track this companyFree. Adds Guangzhou Henovcom Bioscience Co. Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials51 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- HNC042 multiple ascending dosesPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- HNC042 single dosePhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- HNC1058 CapsulesPhase 1 · IPFClinicalTrials.gov · fetched Nov 12, 2026
- HNC364Phase 1 · Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- HNC364 Injectable SuspensionPhase 1 · Parkinson's Disease (PD)ClinicalTrials.gov · fetched Nov 12, 2026
- HNC664 capsules FEDPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- HNC664 capsules Single dosePhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Rasagiline TabletsPhase 1 · Parkinson's Disease (PD)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Relative Bioavailability Study of HNC364 Injectable SuspensionPHASE1 · ACTIVE_NOT_RECRUITING · started May 8, 2026ClinicalTrials.gov NCT06798519 · fetched Nov 12, 2026
- A Study to Evaluate the Safety, Tolerability, PK and PD of HNC1058PHASE1 · COMPLETED · started Mar 28, 2023ClinicalTrials.gov NCT05803850 · fetched Nov 12, 2026
- A Study to Evaluate the Safety, Tolerability, PK and PD of HNC364 Injectable SuspensionPHASE1 · COMPLETED · started Aug 22, 2022ClinicalTrials.gov NCT05523570 · fetched Nov 12, 2026
- A Study of HNC664 in Healthy Subjects to Evaluate the Safety, Tolerability, and PharmacokineticsPHASE1 · COMPLETED · started Aug 11, 2020ClinicalTrials.gov NCT04504448 · fetched Nov 12, 2026
- A Study of HNC042 in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics.PHASE1 · COMPLETED · started Nov 9, 2018ClinicalTrials.gov NCT03740555 · fetched Nov 12, 2026